Atrial Fibrillation
Issues in Management of AF
Should We Maintain Sinus Rhythm?
The AFFIRM trial
The SAFE-T trial- amiodarone vs sotalol vs placebo
Anticoagulation in AF
Risk of Thromboembolism-CHADS2
"Moderate Risk" Patients
"High-Risk" Patients
Secondary Prevention
Target INR level for AF patients
Maintain INR in theurapeutic range
Clopidogrel
Anticoagulation slightly better than Clopidogrel with Aspirin
Clopidogrel with Asprin better than Aspirin alone for those not eligible for anticoagulation
Cardioversion
Role of Transoesophageal Echo in Cardioversion
Use of ACE-inhibitors or ARBs
ACE-inhibitors may reduce the risk of recurrent PAF in those with lone PAF
Non-Pharmacological Therapy
Options
Right Column